Golomb Fm

A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.

Day Cl, Sober Aj, Kopf Aw et al. · PubMed · 1981 · 89 citations

DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).

Carter Rd, Krementz Et, Hill Gj et al. · PubMed · 1976 · 46 citations

Study Utilized Dtic, Skin Cancer, Medicine +14

DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.

Hill Gj, Metter Ge, Krementz Et et al. · PubMed · 1980 · 31 citations

Medicine, Melanoma, Immune Checkpoint Inhibitor +8

Preliminary clinical study of mithramycin (nsc-24559) in primary tumors of the central nervous system.

Joseph Ransohoff, Martin Bf, Medrek Tj et al. · PubMed · 1965 · 20 citations

Preliminary Clinical Study, Neuro-oncology, Tumoral Pathology +10

Remissions produced with the use of Methotrexate in patients with mycosis fungoides.

Wright Jc, Gumport Sl, Golomb Fm · PubMed · 1960 · 19 citations

Autoimmune Disease, Immunology, Clinical Mycology +4